{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:29:34Z","timestamp":1794522574451,"version":"4.9.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11439-8","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T13:45:35Z","timestamp":1754660735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prevalence and contributing factors of drug-resistant tuberculosis (DR-TB) in iran: a systematic review"],"prefix":"10.1186","volume":"25","author":[{"given":"Salman","family":"Daneshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0012-4698","authenticated-orcid":false,"given":"Esmaeil Barkhori","family":"Mehni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshagh","family":"Barfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh Bagher","family":"Barahouei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiavash","family":"Hushmandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5998-5209","authenticated-orcid":false,"given":"Rasoul","family":"Raesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"issue":"3","key":"11439_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2174\/011573398X318641240914123736","volume":"21","author":"R Faryabi","year":"2025","unstructured":"Faryabi R, Kamali A, Raesi R, Hushmandi K, Tabatabaee SS, Askarpour H, Samakkhah SA, Daneshi S. Effects of COVID-19 pandemic on pulmonary tuberculosis (TB) occurrence in the South of Iran. Curr Respiratory Med Reviews. 2025;21(3):267\u201375.","journal-title":"Curr Respiratory Med Reviews"},{"key":"11439_CR2","volume-title":"Global tuberculosis report 2021: supplementary material","author":"WH Organization","year":"2022","unstructured":"Organization WH. Global tuberculosis report 2021: supplementary material. World Health Organization; 2022."},{"issue":"4","key":"11439_CR3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4046\/trd.2016.79.4.201","volume":"79","author":"SH Lee","year":"2016","unstructured":"Lee SH. Tuberculosis infection and latent tuberculosis. Tuberc Respir Dis. 2016;79(4):201.","journal-title":"Tuberc Respir Dis"},{"issue":"1","key":"11439_CR4","doi-asserted-by":"publisher","first-page":"e18749445275993","DOI":"10.2174\/0118749445275993240104084831","volume":"17","author":"R Faryabi","year":"2024","unstructured":"Faryabi R, Raesi R, Taghdisi Heydarian SM, Daneshi S, Kermani B, Hushmandi K, Barfar E. Evaluation of the tuberculosis surveillance system in the Southern Region of Iran. Open Public Health J. 2024;17(1):e18749445275993.","journal-title":"Open Public Health J"},{"key":"11439_CR5","first-page":"IDRT","volume":"6","author":"BA Talip","year":"2013","unstructured":"Talip BA, Sleator RD, Lowery CJ, Dooley JS, Snelling WJ. An update on global tuberculosis (TB). Infect Diseases: Res Treat. 2013;6:IDRT. S11263.","journal-title":"Infect Diseases: Res Treat"},{"issue":"3","key":"11439_CR6","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/cid\/ciae561","volume":"80","author":"JH Puyat","year":"2025","unstructured":"Puyat JH, Brode SK, Shulha H, Romanowski K, Menzies D, Benedetti A, Duchen R, Huang A, Fang J, Macdonald L. Predicting risk of tuberculosis (TB) disease in people who migrate to a Low-TB incidence country: development and validation of a multivariable, dynamic risk-Prediction model using health administrative data. Clin Infect Dis. 2025;80(3):644\u201352.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"11439_CR7","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RM Houben","year":"2016","unstructured":"Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 2016;13(10):e1002152.","journal-title":"PLoS Med"},{"key":"11439_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2147\/PPA.S238024","volume":"14","author":"N Gustafsson","year":"2020","unstructured":"Gustafsson N, Leino-Kilpi H, Prga I, Suhonen R, Stolt M. Action\u2013CA15208 RcC: Missed care from the patient\u2019s perspective\u2013a scoping review. Patient Prefer Adherence. 2020;14:383\u2013400.","journal-title":"Patient Prefer Adherence"},{"key":"11439_CR9","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/j.ijid.2022.03.011","volume":"124","author":"J Chakaya","year":"2022","unstructured":"Chakaya J, Petersen E, Nantanda R, Mungai BN, Migliori GB, Amanullah F, Lungu P, Ntoumi F, Kumarasamy N, Maeurer M. The WHO global tuberculosis 2021 Report\u2013not so good news and turning the tide back to end TB. Int J Infect Dis. 2022;124:S26\u20139.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"11439_CR10","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","volume":"4","author":"S Bagcchi","year":"2023","unstructured":"Bagcchi S. WHO\u2019s global tuberculosis report 2022. Lancet Microbe. 2023;4(1):e20.","journal-title":"Lancet Microbe"},{"issue":"3","key":"11439_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.idm.2024.05.003","volume":"9","author":"M Rastegar","year":"2024","unstructured":"Rastegar M, Nazar E, Nasehi M, Sharafi S, Fakoor V, Shakeri MT. Bayesian Estimation of the time-varying reproduction number for pulmonary tuberculosis in iran: a registry-based study from 2018 to 2022 using new smear-positive cases. Infect Disease Modelling. 2024;9(3):963\u201374.","journal-title":"Infect Disease Modelling"},{"key":"11439_CR12","doi-asserted-by":"publisher","first-page":"1408316","DOI":"10.3389\/fpubh.2024.1408316","volume":"12","author":"H-W Song","year":"2024","unstructured":"Song H-W, Tian J-H, Song H-P, Guo S-J, Lin Y-H, Pan J-S. Tracking multidrug resistant tuberculosis: a 30-year analysis of global, regional, and National trends. Front Public Health. 2024;12:1408316.","journal-title":"Front Public Health"},{"issue":"2","key":"11439_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5530\/jyp.2024.16.21","volume":"16","author":"V Srivastava","year":"2024","unstructured":"Srivastava V, Verma A. Current challenges in the management of tuberculosis. J Young Pharmacists. 2024;16(2):145\u201354.","journal-title":"J Young Pharmacists"},{"key":"11439_CR14","volume-title":"Social support and treatment outcomes among multi-drug-resistant tuberculosis and persons living with HIV in Nigeria","author":"AO Hassan","year":"2025","unstructured":"Hassan AO. Social support and treatment outcomes among multi-drug-resistant tuberculosis and persons living with HIV in Nigeria. Walden University; 2025."},{"issue":"11","key":"11439_CR15","first-page":"2572","volume":"53","author":"R Ehsani","year":"2024","unstructured":"Ehsani R, Sharafoddin M, Olyaeemanesh A, Delavari A, Vosoogh-Moghaddam A, Alimohamadi Y, Ghorbani S. Insights into health program implementation and evaluation in iran: A brief review of National healthcare programs in Iran. Iran J Public Health. 2024;53(11):2572.","journal-title":"Iran J Public Health"},{"issue":"11","key":"11439_CR16","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.ajic.2014.07.017","volume":"42","author":"MJ Nasiri","year":"2014","unstructured":"Nasiri MJ, Dabiri H, Darban-Sarokhalil D, Rezadehbashi M, Zamani S. Prevalence of drug-resistant tuberculosis in iran: systematic review and meta-analysis. Am J Infect Control. 2014;42(11):1212\u20138.","journal-title":"Am J Infect Control"},{"issue":"3","key":"11439_CR17","doi-asserted-by":"publisher","first-page":"320","DOI":"10.4103\/ijmy.ijmy_162_24","volume":"13","author":"S Ayoubi","year":"2024","unstructured":"Ayoubi S, Farnia P, Farnia P, Ghanavi J, Velayati AA. Prevalence and Temporal trends of multidrug-resistant tuberculosis in Iran from 1981 to 2023: a systematic review and meta-analysis. Int J Mycobacteriology. 2024;13(3):320\u201330.","journal-title":"Int J Mycobacteriology"},{"issue":"2","key":"11439_CR18","first-page":"e35154","volume":"15","author":"K Chowdhury","year":"2023","unstructured":"Chowdhury K, Ahmad R, Sinha S, Dutta S, Haque M. Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) among children: where we stand now. Cureus. 2023;15(2):e35154.","journal-title":"Cureus"},{"key":"11439_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coph.2018.05.013","volume":"42","author":"A Koch","year":"2018","unstructured":"Koch A, Cox H, Mizrahi V. Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment. Curr Opin Pharmacol. 2018;42:7\u201315.","journal-title":"Curr Opin Pharmacol"},{"issue":"4","key":"11439_CR20","doi-asserted-by":"publisher","first-page":"e00180","DOI":"10.1128\/cmr.00180-19","volume":"35","author":"N Dookie","year":"2022","unstructured":"Dookie N, Ngema SL, Perumal R, Naicker N, Padayatchi N, Naidoo K. The changing paradigm of drug-resistant tuberculosis treatment: successes, pitfalls, and future perspectives. Clin Microbiol Rev. 2022;35(4):e00180\u201300119.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"11439_CR21","doi-asserted-by":"publisher","first-page":"999","DOI":"10.15212\/ZOONOSES-2024-0061","volume":"5","author":"Z Chen","year":"2025","unstructured":"Chen Z, Wang T, Du J, Sun L, Wang G, Ni R, An Y, Fan X, Li Y, Guo R. Decoding the WHO global tuberculosis report 2024: A critical analysis of global and Chinese key data. Zoonoses. 2025;5(1):999.","journal-title":"Zoonoses"},{"issue":"5","key":"11439_CR22","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3390\/pharmaceutics13050592","volume":"13","author":"F Stephanie","year":"2021","unstructured":"Stephanie F, Saragih M, Tambunan USF. Recent progress and challenges for drug-resistant tuberculosis treatment. Pharmaceutics. 2021;13(5):592.","journal-title":"Pharmaceutics"},{"issue":"3","key":"11439_CR23","first-page":"e37866","volume":"10","author":"AZ Bialvaei","year":"2017","unstructured":"Bialvaei AZ, Asgharzadeh M, Aghazadeh M, Nourazarian M, Kafil HS. Challenges of tuberculosis in Iran. Jundishapur J Microbiol. 2017;10(3):e37866.","journal-title":"Jundishapur J Microbiol"},{"issue":"1","key":"11439_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4103\/jpdtsm.jpdtsm_144_23","volume":"3","author":"N Madadi-Goli","year":"2024","unstructured":"Madadi-Goli N, Ahmadi K, Meskini M, Vaziri F, Fateh A, Siadat SD. Tuberculosis prevention, diagnosis, and treatment financial profile during 2006\u20132021: part B. J Prev Diagn Treat Strategies Med. 2024;3(1):37\u201343.","journal-title":"J Prev Diagn Treat Strategies Med"},{"issue":"3","key":"11439_CR25","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3329\/bjms.v17i3.37002","volume":"17","author":"M Moosazadeh","year":"2018","unstructured":"Moosazadeh M, Amiresmaili M. Challenges in case finding of tuberculosis control program in iran: A qualitative study. Bangladesh J Med Sci. 2018;17(3):462\u20139.","journal-title":"Bangladesh J Med Sci"},{"key":"11439_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.puhe.2019.03.008","volume":"171","author":"P Kazerooni","year":"2019","unstructured":"Kazerooni P, Nejat M, Akbarpoor M, Sedaghat Z, Fararouei M. Underascertainment, underreporting, representativeness and timeliness of the Iranian communicable disease surveillance system for tuberculosis. Public Health. 2019;171:50\u20136.","journal-title":"Public Health"},{"issue":"1","key":"11439_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.18869\/modares.iem.3.1.25","volume":"3","author":"F Khademi","year":"2017","unstructured":"Khademi F, Yousefi-Avarvand A, Derakhshan M, Vaez H, Sadeghi R. Middle East Mycobacterium tuberculosis antibiotic resistance: a systematic review and meta-analysis. Infect Epidemiol Microbiol. 2017;3(1):25\u201335.","journal-title":"Infect Epidemiol Microbiol"},{"key":"11439_CR28","doi-asserted-by":"publisher","first-page":"100430","DOI":"10.1016\/j.jctube.2024.100430","volume":"35","author":"S Abbasian","year":"2024","unstructured":"Abbasian S, Heidari H, Tadi DA, Kardan-Yamchi J, Taji A, Darbandi A, Asadollahi P, Maleki A, Kazemian H. Epidemiology of first-and second-line drugs-resistant pulmonary tuberculosis in iran: systematic review and meta-analysis. J Clin Tuberculosis Other Mycobact Dis. 2024;35:100430.","journal-title":"J Clin Tuberculosis Other Mycobact Dis"},{"issue":"6","key":"11439_CR29","first-page":"720","volume":"24","author":"F Bahraminia","year":"2021","unstructured":"Bahraminia F, Azimi T, Zangiabadian M, Nasiri MJ, Goudarzi M, Dadashi M, Fooladi AAI. Rifampicin-resistant tuberculosis in iran: A systematic review and meta-analysis. Iran J Basic Med Sci. 2021;24(6):720.","journal-title":"Iran J Basic Med Sci"},{"key":"11439_CR30","doi-asserted-by":"publisher","first-page":"e18628","DOI":"10.7717\/peerj.18628","volume":"12","author":"A Alibrahim","year":"2024","unstructured":"Alibrahim A, Alqahtani H, Thirunavukkarasu A, Qazi I. Prevalence, patterns, and determinants of drug-resistant tuberculosis in Gulf Cooperation Council countries: an updated systematic review. PeerJ. 2024;12:e18628.","journal-title":"PeerJ"},{"issue":"3","key":"11439_CR31","first-page":"PID26","volume":"1","author":"MA Munir","year":"2024","unstructured":"Munir MA, Khan S, Rehman S, Ahmed D, Jabbar A. Tuberculosis among diabetes patients: a review of epidemiology, pathophysiology, clinical manifestations, and management. Chronicles Biomedical Sci. 2024;1(3):PID26\u201326.","journal-title":"Chronicles Biomedical Sci"},{"key":"11439_CR32","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"11439_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6947-7-1","volume":"7","author":"C Schardt","year":"2007","unstructured":"Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching pubmed for clinical questions. BMC Med Inf Decis Mak. 2007;7:1\u20136.","journal-title":"BMC Med Inf Decis Mak"},{"key":"11439_CR34","doi-asserted-by":"publisher","first-page":"102569","DOI":"10.1016\/j.mex.2024.102569","volume":"12","author":"M Sguanci","year":"2024","unstructured":"Sguanci M, Mancin S, Piredda M, De Marinis MG. Protocol for conducting a systematic review on diagnostic accuracy in clinical research. MethodsX. 2024;12:102569.","journal-title":"MethodsX"},{"issue":"10","key":"11439_CR35","first-page":"2127","volume":"18","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, Stephenson M, Aromataris E. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synthesis. 2020;18(10):2127\u201333.","journal-title":"JBI Evid Synthesis"},{"key":"11439_CR36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1053\/j.jrn.2024.04.005","volume":"34","author":"M Sguanci","year":"2024","unstructured":"Sguanci M, Ferrara G, Palomares SM, Parozzi M, Godino L, Gazineo D, Anastasi G, Mancin S. Dysgeusia and chronic kidney disease: a scoping review. J Ren Nutr. 2024;34:374.","journal-title":"J Ren Nutr"},{"key":"11439_CR37","unstructured":"Howick J. The Oxford 2011 levels of evidence. http:\/\/www.cebm.net \/index aspx? o\u2009=\u20095653 2011."},{"key":"11439_CR38","doi-asserted-by":"publisher","first-page":"102532","DOI":"10.1016\/j.mex.2023.102532","volume":"12","author":"S Mancin","year":"2024","unstructured":"Mancin S, Sguanci M, Andreoli D, Soekeland F, Anastasi G, Piredda M, De Marinis MG. Systematic review of clinical practice guidelines and systematic reviews: a method for conducting comprehensive analysis. MethodsX. 2024;12:102532.","journal-title":"MethodsX"},{"issue":"3","key":"11439_CR39","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1089\/mdr.2014.0075","volume":"21","author":"P Mohajeri","year":"2015","unstructured":"Mohajeri P, Sadri H, Farahani A, Norozi B, Atashi S. Frequency of mutations associated with rifampicin resistance in Mycobacterium tuberculosis strains isolated from patients in West of Iran. Microb Drug Resist. 2015;21(3):315\u20139.","journal-title":"Microb Drug Resist"},{"issue":"1","key":"11439_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1089\/mdr.2009.0073","volume":"16","author":"P Tabarsi","year":"2010","unstructured":"Tabarsi P, Chitsaz E, Baghaei P, Shamaei M, Farnia P, Marjani M, Kazempour M, Amiri M, Mansouri D, Masjedi MR. Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran. Microb Drug Resist. 2010;16(1):81\u20136.","journal-title":"Microb Drug Resist"},{"issue":"2","key":"11439_CR41","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1378\/chest.08-2427","volume":"136","author":"AA Velayati","year":"2009","unstructured":"Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, ZiaZarifi AH, Hoffner SE. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest. 2009;136(2):420\u20135.","journal-title":"Chest"},{"issue":"10","key":"11439_CR42","first-page":"DC05","volume":"10","author":"P Mohajeri","year":"2016","unstructured":"Mohajeri P, Moradi S, Atashi S, Farahani A. Mycobacterium tuberculosis Beijing genotype in Western iran: distribution and drug resistance. J Clin Diagn Research: JCDR. 2016;10(10):DC05.","journal-title":"J Clin Diagn Research: JCDR"},{"issue":"4","key":"11439_CR43","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1089\/mdr.2008.0842","volume":"14","author":"F Doustdar","year":"2008","unstructured":"Doustdar F, Khosravi AD, Farnia P, Masjedi MR, Velayati AA. Molecular analysis of Isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran. Microb Drug Resist. 2008;14(4):273\u20139.","journal-title":"Microb Drug Resist"},{"key":"11439_CR44","unstructured":"Lee H, Kim J, Kim J, Park Y-J. Review of the global burden of tuberculosis in 2023: insights from the WHO Global Tuberculosis Report 2024. 2025."},{"key":"11439_CR45","unstructured":"Tuberculosis. incidence in Iran. https:\/\/www.theglobaleconomy.com\/Iran\/Tuberculosis\/?utm_source=chatgpt.com"},{"key":"11439_CR46","doi-asserted-by":"publisher","first-page":"100354","DOI":"10.1016\/j.jctube.2023.100354","volume":"31","author":"A Ebrahimzadeh","year":"2023","unstructured":"Ebrahimzadeh A, Pagheh AS, Mousavi T, Fathi M, Moghaddam SGM. Serosal membrane tuberculosis in iran: A comprehensive review of evidences. J Clin Tuberculosis Other Mycobact Dis. 2023;31:100354.","journal-title":"J Clin Tuberculosis Other Mycobact Dis"},{"issue":"6","key":"11439_CR47","first-page":"92","volume":"9","author":"L Yuanyuan","year":"2025","unstructured":"Yuanyuan L, Jingjing X, Shutao L, Dongdong S, Tian Z, Puxuan L, Yi P. 2024 WHO tuberculosis report: key data analysis for China and the global world. Electron J Emerg Infect Dis. 2025;9(6):92.","journal-title":"Electron J Emerg Infect Dis"},{"issue":"9907","key":"11439_CR48","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/S0140-6736(13)62078-4","volume":"382","author":"A Zumla","year":"2013","unstructured":"Zumla A, George A, Sharma V, Herbert N. WHO\u2019s 2013 global report on tuberculosis: successes, threats, and opportunities. Lancet. 2013;382(9907):1765\u20137.","journal-title":"Lancet"},{"issue":"1","key":"11439_CR49","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12875-022-01919-0","volume":"23","author":"Z Gizaw","year":"2022","unstructured":"Gizaw Z, Astale T, Kassie GM. What improves access to primary healthcare services in rural communities? A systematic review. BMC Prim Care. 2022;23(1):313.","journal-title":"BMC Prim Care"},{"issue":"6","key":"11439_CR50","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.puhe.2015.04.001","volume":"129","author":"N Douthit","year":"2015","unstructured":"Douthit N, Kiv S, Dwolatzky T, Biswas S. Exposing some important barriers to health care access in the rural USA. Public Health. 2015;129(6):611\u201320.","journal-title":"Public Health"},{"key":"11439_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12939-017-0671-2","volume":"16","author":"SW Yu","year":"2017","unstructured":"Yu SW, Hill C, Ricks ML, Bennet J, Oriol NE. The scope and impact of mobile health clinics in the united states: a literature review. Int J Equity Health. 2017;16:1\u201312.","journal-title":"Int J Equity Health"},{"issue":"10","key":"11439_CR52","doi-asserted-by":"publisher","first-page":"943","DOI":"10.15171\/ijhpm.2018.53","volume":"7","author":"S Javanparast","year":"2018","unstructured":"Javanparast S, Windle A, Freeman T, Baum F. Community health worker programs to improve healthcare access and equity: are they only relevant to low-and middle-income countries? Int J Health Policy Manage. 2018;7(10):943.","journal-title":"Int J Health Policy Manage"},{"key":"11439_CR53","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.2147\/RMHP.S432943","volume":"16","author":"MH Nunemo","year":"2023","unstructured":"Nunemo MH, Gidebo KD, Woticha EW, Lemu YK. Integration challenges and opportunity of implementing non-communicable disease screening intervention with tuberculosis patient care: A mixed implementation study. Risk Manage Healthc Policy. 2023;16:2609\u201333.","journal-title":"Risk Manage Healthc Policy"},{"issue":"1","key":"11439_CR54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12913-022-07612-3","volume":"22","author":"M Arini","year":"2022","unstructured":"Arini M, Sugiyo D, Permana I. Challenges, opportunities, and potential roles of the private primary care providers in tuberculosis and diabetes mellitus collaborative care and control: a qualitative study. BMC Health Serv Res. 2022;22(1):215.","journal-title":"BMC Health Serv Res"},{"issue":"9","key":"11439_CR55","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/nutrit\/nuad120","volume":"82","author":"F Wagnew","year":"2024","unstructured":"Wagnew F, Gray D, Tsheten T, Kelly M, Clements AC, Alene KA. Effectiveness of nutritional support to improve treatment adherence in patients with tuberculosis: a systematic review. Nutr Rev. 2024;82(9):1216\u201325.","journal-title":"Nutr Rev"},{"issue":"1","key":"11439_CR56","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12890-023-02440-5","volume":"23","author":"SS Saidi","year":"2023","unstructured":"Saidi SS, Abdul Manaf R. Effectiveness of family support health education intervention to improve health-related quality of life among pulmonary tuberculosis patients in melaka, Malaysia. BMC Pulm Med. 2023;23(1):139.","journal-title":"BMC Pulm Med"},{"issue":"3","key":"11439_CR57","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/antibiotics3030317","volume":"3","author":"JC Palomino","year":"2014","unstructured":"Palomino JC, Martin A. Drug resistance mechanisms in Mycobacterium tuberculosis. Antibiotics. 2014;3(3):317\u201340.","journal-title":"Antibiotics"},{"issue":"11","key":"11439_CR58","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1128\/JCM.00812-10","volume":"48","author":"MV Ramirez","year":"2010","unstructured":"Ramirez MV, Cowart KC, Campbell PJ, Morlock GP, Sikes D, Winchell JM, Posey JE. Rapid detection of Multidrug-Resistant Mycobacterium tube rculosis by use of Real-Time PCR and High-Resolution melt analysis. J Clin Microbiol. 2010;48(11):4003\u20139.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"11439_CR59","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1128\/JCM.02036-09","volume":"48","author":"DC Ong","year":"2010","unstructured":"Ong DC, Yam W-C, Siu GK, Lee AS. Rapid detection of rifampicin-and isoniazid-resistant Mycobacterium tuberculosis by high-resolution melting analysis. J Clin Microbiol. 2010;48(4):1047\u201354.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"11439_CR60","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1128\/JCM.01264-13","volume":"51","author":"X Yin","year":"2013","unstructured":"Yin X, Zheng L, Liu Q, Lin L, Hu X, Hu Y, Wang Q. High-resolution melting curve analysis for rapid detection of Rifampin resistance in Mycobacterium tuberculosis: a meta-analysis. J Clin Microbiol. 2013;51(10):3294\u20139.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"11439_CR61","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/S1473-3099(15)00062-6","volume":"15","author":"TM Walker","year":"2015","unstructured":"Walker TM, Kohl TA, Omar SV, Hedge J, Elias CDO, Bradley P, Iqbal Z, Feuerriegel S, Niehaus KE, Wilson DJ. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis. 2015;15(10):1193\u2013202.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"11439_CR62","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2174\/18734316MTA3kNzEjw","volume":"22","author":"BA Sheikh","year":"2021","unstructured":"Sheikh BA, Bhat BA, Mehraj U, Mir W, Hamadani S, Mir MA. Development of new therapeutics to Meet the current challenge of drug resistant tuberculosis. Curr Pharm Biotechnol. 2021;22(4):480\u2013500.","journal-title":"Curr Pharm Biotechnol"},{"issue":"9","key":"11439_CR63","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.3390\/molecules26092671","volume":"26","author":"M Terreni","year":"2021","unstructured":"Terreni M, Taccani M, Pregnolato M. New antibiotics for multidrug-resistant bacterial strains: latest research developments and future perspectives. Molecules. 2021;26(9):2671.","journal-title":"Molecules"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11439-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11439-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11439-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:44:18Z","timestamp":1757346258000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11439-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11439"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11439-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"During the preparation of this work, the authors used ChatGPT in order to check the grammar and improve readability. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1004"}}